US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Adma Biologics Inc (ADMA)
Adma Biologics Inc (ADMA) ニュース

ADMA

Adma Biologics (ADMA)

Adma Biologics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ADMA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/17	20 : 00	GlobeNewswire Inc.	ADMA Biologics Set to Join S&P SmallCap 600 Index	NASDAQ:ADMA	Adma Biologics Inc
2024/09/12	10 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/09/10	20 : 00	GlobeNewswire Inc.	ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference	NASDAQ:ADMA	Adma Biologics Inc
2024/09/10	10 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/09/07	07 : 43	PR Newswire (US)	Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600	NASDAQ:ADMA	Adma Biologics Inc
2024/08/31	10 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/08/31	10 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/08/31	10 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/08/31	10 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/08/31	10 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/08/30	10 : 26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/08/28	10 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/08/28	10 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/08/27	10 : 28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/08/14	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADMA	Adma Biologics Inc
2024/08/14	21 : 59	GlobeNewswire Inc.	ADMA Biologics Announces Partial Paydown of Revolving Credit Facility	NASDAQ:ADMA	Adma Biologics Inc
2024/08/09	06 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ADMA	Adma Biologics Inc
2024/08/09	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADMA	Adma Biologics Inc
2024/08/09	05 : 05	GlobeNewswire Inc.	ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:ADMA	Adma Biologics Inc
2024/08/01	20 : 00	GlobeNewswire Inc.	ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024	NASDAQ:ADMA	Adma Biologics Inc
2024/07/27	10 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/07/27	10 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/07/27	10 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/07/27	10 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/07/27	10 : 00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/07/27	10 : 00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/07/27	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADMA	Adma Biologics Inc
2024/06/15	10 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/06/15	06 : 15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ADMA	Adma Biologics Inc
2024/06/05	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADMA	Adma Biologics Inc

Showing the most relevant articles for your search:NASDAQ:ADMA

1 2 3 4 5 6 7 8 9 10 次へ >>

Energy Select Sector SPDR

US Dollar vs Sterling

Health Care Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約